Divi's Laboratories Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.
DIVISLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Divi's Laboratories reported strong FY2025-26 results with consolidated total income of ₹11,067 crores (up 13.9% from ₹9,712 crores). Standalone PAT grew 18% to ₹2,607 crores from ₹2,209 crores, while consolidated PAT increased 17.2% to ₹2,568 crores. The Board recommended a dividend of ₹30 per share (1,500% on face value ₹2). An exceptional charge of ₹74 crores was recognized due to the implementation of new Labour Codes (affecting employee benefit expenses). Foreign exchange gains contributed ₹211 crores during the year versus ₹48 crores in the prior year. The company maintained an unmodified audit opinion from Price Waterhouse Chartered Accountants LLP.
The results show solid double-digit revenue and profit growth driven by better forex gains, though underlying operating performance shows margin improvement. The ₹74 crore Labour Code impact was one-time and properly disclosed under exceptional items. Positive dividend announcement signals confidence in cash generation.